ACO Coordinated Care Also Means Coordinated Review Of Drugs’ Value
This article was originally published in The Pink Sheet Daily
Executive Summary
An executive from an accountable care organization in Massachusetts gives an example of how different groups of medical experts within the organization can coordinate to determine which medical products should be preferred based on cost effectiveness.
You may also be interested in...
ACO Rx Survey Suggests Ways To Help Integrate Drug Use Into Care
A recent report finds many gaps in accountable care organizations’ abilities to support, monitor and ensure appropriate use of medications, and a group headed by the National Pharmaceutical Council aims to address them as it continues developing an ACO toolkit for medication management.
Looking Ahead To 2012: ACOs Get In Gear, Accelerating The Need to Prove Biopharma Products' Overall Value In Health Care
Thirty-two "Pioneer" accountable care organizations began operations with the new year.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.